Shanghai Kaibao Pharmaceutical (300039) — Cash Flow-to-Debt Ratio
Shanghai Kaibao Pharmaceutical (300039) has a Cash Flow-to-Debt Ratio of 0.46x as of September 2025, meaning its operating cash flow of CN¥190.98 Million could theoretically repay 0% of its total liabilities (CN¥412.55 Million) in one year. See 300039 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Kaibao Pharmaceutical Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Shanghai Kaibao Pharmaceutical across 19 annual periods. Also explore 300039 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai Kaibao Pharmaceutical (2006–2024)
Year-by-year debt coverage analysis for Shanghai Kaibao Pharmaceutical. For market capitalisation and broader financial context, see 300039 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.67x | CN¥278.95 Million | CN¥415.45 Million | ▼ -4.1% |
| 2023 | 0.70x | CN¥382.66 Million | CN¥546.82 Million | ▼ -7.4% |
| 2022 | 0.76x | CN¥376.42 Million | CN¥498.24 Million | ▲ +86.3% |
| 2021 | 0.41x | CN¥126.08 Million | CN¥310.90 Million | ▼ -51.6% |
| 2020 | 0.84x | CN¥250.65 Million | CN¥298.96 Million | ▼ -31.5% |
| 2019 | 1.22x | CN¥334.09 Million | CN¥273.01 Million | ▲ +22.3% |
| 2018 | 1.00x | CN¥262.36 Million | CN¥262.26 Million | ▲ +27.9% |
| 2017 | 0.78x | CN¥245.76 Million | CN¥314.26 Million | ▼ -18.6% |
| 2016 | 0.96x | CN¥314.88 Million | CN¥327.61 Million | ▲ +23.8% |
| 2015 | 0.78x | CN¥327.08 Million | CN¥421.16 Million | ▼ -36.0% |
| 2014 | 1.21x | CN¥282.38 Million | CN¥232.72 Million | ▼ -26.0% |
| 2013 | 1.64x | CN¥270.23 Million | CN¥164.72 Million | ▼ -4.1% |
| 2012 | 1.71x | CN¥243.32 Million | CN¥142.29 Million | ▲ +105.2% |
| 2011 | 0.83x | CN¥98.31 Million | CN¥117.97 Million | ▲ +461.7% |
| 2010 | 0.15x | CN¥19.79 Million | CN¥133.39 Million | ▼ -44.0% |
| 2009 | 0.26x | CN¥52.74 Million | CN¥199.20 Million | ▲ +45.8% |
| 2008 | 0.18x | CN¥18.70 Million | CN¥102.95 Million | ▼ -33.9% |
| 2007 | 0.27x | CN¥23.27 Million | CN¥84.64 Million | ▲ +0.2% |
| 2006 | 0.27x | CN¥19.70 Million | CN¥71.80 Million | — |